These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
590 related items for PubMed ID: 16125778
1. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT. Panhotra BR, Bahrani A, Joshi CS, ul Hassan Z. J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778 [No Abstract] [Full Text] [Related]
2. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Kuhns MC, Kleinman SH, McNamara AL, Rawal B, Glynn S, Busch MP, REDS Study Group. Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857 [Abstract] [Full Text] [Related]
3. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? Stramer SL, Zou S, Notari EP, Foster GA, Krysztof DE, Musavi F, Dodd RY. Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101 [Abstract] [Full Text] [Related]
4. Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Kleinman SH, Strong DM, Tegtmeier GG, Holland PV, Gorlin JB, Cousins C, Chiacchierini RP, Pietrelli LA. Transfusion; 2005 Aug; 45(8):1247-57. PubMed ID: 16078909 [Abstract] [Full Text] [Related]
5. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Busch MP. Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546 [Abstract] [Full Text] [Related]
6. Donor screening for hepatitis B virus infection in a cell and tissue bank. Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ. Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905 [Abstract] [Full Text] [Related]
8. Nucleic acid testing to detect HBV infection in blood donors. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W. N Engl J Med; 2011 Jan 20; 364(3):236-47. PubMed ID: 21247314 [Abstract] [Full Text] [Related]
9. Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela. Gutiérrez C, Devesa M, Loureiro CL, León G, Liprandi F, Pujol FH. J Med Virol; 2004 Jun 20; 73(2):200-7. PubMed ID: 15122793 [Abstract] [Full Text] [Related]
10. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations. Bouchardeau F, Girault A, Razer A, Servant-Delmas A, Mercier M, Laperche S. Transfusion; 2006 Dec 20; 46(12):2047-52. PubMed ID: 17176315 [Abstract] [Full Text] [Related]
11. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E. Transfusion; 2007 Jan 20; 47(1):74-9. PubMed ID: 17207233 [Abstract] [Full Text] [Related]
12. Italian blood donors with anti-HBc and occult hepatitis B virus infection. Manzini P, Girotto M, Borsotti R, Giachino O, Guaschino R, Lanteri M, Testa D, Ghiazza P, Vacchini M, Danielle F, Pizzi A, Valpreda C, Castagno F, Curti F, Magistroni P, Abate ML, Smedile A, Rizzetto M. Haematologica; 2007 Dec 20; 92(12):1664-70. PubMed ID: 18055990 [Abstract] [Full Text] [Related]
13. Hepatitis B virus nucleic acid amplification testing of Australian blood donors highlights the complexity of confirming occult hepatitis B virus infection. Kiely P, Margaritis AR, Seed CR, Yang H, Australian Red Cross Blood Service NAT Study Group. Transfusion; 2014 Aug 20; 54(8):2084-91. PubMed ID: 24650170 [Abstract] [Full Text] [Related]
14. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program. Satake M, Taira R, Yugi H, Hino S, Kanemitsu K, Ikeda H, Tadokoro K. Transfusion; 2007 Jul 20; 47(7):1197-205. PubMed ID: 17581154 [Abstract] [Full Text] [Related]
15. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg]. Ren F, Li H, Zhao H. Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan 20; 32(1):7-9. PubMed ID: 10322742 [Abstract] [Full Text] [Related]
16. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks. Bamaga MS, Azahar EI, Al-Ghamdi AK, Alenzi FQ, Farahat FM. Saudi Med J; 2009 Nov 20; 30(11):1416-21. PubMed ID: 19882053 [Abstract] [Full Text] [Related]
17. Blood donor screening in the Netherlands: Universal anti-HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing. van de Laar TJ, Hogema BM, Molenaar-de Backer MW, Marijt-van der Kreek T, Zaaijer HL. Transfusion; 2021 Jul 20; 61(7):2116-2124. PubMed ID: 33899233 [Abstract] [Full Text] [Related]
18. Occult hepatitis B virus infection: implications in transfusion. Allain JP. Vox Sang; 2004 Feb 20; 86(2):83-91. PubMed ID: 15023176 [Abstract] [Full Text] [Related]
19. Significance of detecting anti-HBc among Egyptian male blood donors negative for HBsAg. Antar W, El-Shokry MH, Abd El Hamid WA, Helmy MF. Transfus Med; 2010 Dec 20; 20(6):409-13. PubMed ID: 20573069 [Abstract] [Full Text] [Related]
20. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen. Katz L, Strong DM, Tegtmeier G, Stramer S. Transfusion; 2008 Nov 20; 48(11):2315-22. PubMed ID: 18647367 [Abstract] [Full Text] [Related] Page: [Next] [New Search]